Regression of metastatic renal-cell carcinoma after nonmyeloablative peripheral-blood stem-cell transplantation. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, Read EJ, Tisdale J, Dunbar C, Linehan WM, Young NS, Barrett AJ, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1652, USA.childsr@nih.gov

Author: Dreicer R.   Dreicer R.   Dreicer R.   Dreicer R.   Dreicer R.  

Publisher: Elsevier

ISSN: 1078-1439

Source: Urologic Oncology: Seminars and Original Investigations, Vol.6, Iss.3, 2001-05, pp. : 125-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content